J. Sackoff, D. Hanna, M. Pfeiffer, and L. Torian, Causes of Death among Persons with AIDS in the Era of Highly Active Antiretroviral Therapy: New York City, Annals of Internal Medicine, vol.145, issue.6, pp.397-406, 2006.
DOI : 10.7326/0003-4819-145-6-200609190-00003

F. Bonnet, C. Lewden, and T. May, Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy, Cancer, vol.26, issue.Suppl 1
DOI : 10.1002/cncr.20354

C. Lewden, T. May, and E. Rosenthal, Changes in Causes of Death Among Adults Infected by HIV Between 2000 and 2005: The ???Mortalit?? 2000 and 2005??? Surveys (ANRS EN19 and Mortavic), JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.48, issue.5, pp.590-598, 2000.
DOI : 10.1097/QAI.0b013e31817efb54

G. Clifford, J. Polesel, and M. Rickenbach, Cancer Risk in the Swiss HIV Cohort Study: Associations With Immunodeficiency, Smoking, and Highly Active Antiretroviral Therapy, JNCI Journal of the National Cancer Institute, vol.97, issue.6, pp.425-457, 2005.
DOI : 10.1093/jnci/dji072

F. Bonnet, E. Balestre, and R. Thiebaut, Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy

E. Engels, R. Pfeiffer, and J. Goedert, Trends in cancer risk among people with AIDS in the United States 1980???2002, AIDS, vol.20, issue.12, pp.1645-54, 2006.
DOI : 10.1097/01.aids.0000238411.75324.59

M. Herida, M. Mary-krause, and R. Kaphan, Incidence of Non???AIDS-Defining Cancers Before and During the Highly Active Antiretroviral Therapy Era in a Cohort of Human Immunodeficiency Virus???Infected Patients, Journal of Clinical Oncology, vol.21, issue.18, pp.3447-53, 2003.
DOI : 10.1200/JCO.2003.01.096

F. Bonnet, C. Burty, and C. Lewden, Changes in Cancer Mortality among HIV???Infected Patients: The Mortalit?? 2005 Survey, Clinical Infectious Diseases, vol.48, issue.5, pp.633-642, 2005.
DOI : 10.1086/596766

A. Benard, J. Tessier, and J. Rambeloarisoa, HIV infection and tobacco smoking behaviour: prospects for prevention? ANRS CO3 Aquitaine Cohort, Int J Tuberc Lung Dis, vol.10, pp.378-83, 2002.

N. Friis-moller, R. Weber, and P. Reiss, Cardiovascular disease risk factors in HIV patients ??? association with antiretroviral therapy. Results from the DAD study, AIDS, vol.17, issue.8, pp.1179-93, 2003.
DOI : 10.1097/00002030-200305230-00010

M. Puoti, R. Bruno, and V. Soriano, Hepatocellular carcinoma in HIV-infected patients, AIDS, vol.18, issue.17, pp.2285-93, 2004.
DOI : 10.1097/00002030-200411190-00009

G. Clifford, M. Rickenbach, and J. Polesel, Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma, AIDS, vol.22, issue.16, pp.2135-2176, 2008.
DOI : 10.1097/QAD.0b013e32831103ad

K. Mack, R. Wei, and B. Herndier, HIV insertional cis-activation of the protooncogene c-fes in AIDS associated lymphomagenesis, Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology, vol.14, issue.4, p.44, 1997.
DOI : 10.1097/00042560-199704010-00155

A. El-solh, N. Kumar, M. Nair, S. Schwartz, and J. Lwebuga-mukasa, An RGD Containing peptide from HIV-1 TAT-(65???80) modulates protooncogene expression in human bronchoalveolar carcinoma cell line, A549, Immunological Investigations, vol.53, issue.3, pp.351-70, 1997.
DOI : 10.1038/345084a0

J. Marsh, B. Herndier, and A. Tsuzuki, Cytokine Expression in Large Cell Lymphoma Associated with Acquired Immunodeficiency Syndrome, Journal of Interferon & Cytokine Research, vol.15, issue.3, pp.261-269, 1995.
DOI : 10.1089/jir.1995.15.261

M. Ott, S. Emiliani, and C. Van-lint, Immune Hyperactivation of HIV-1-Infected T Cells Mediated by Tat and the CD28 Pathway, Science, vol.275, issue.5305, pp.1481-1486, 1997.
DOI : 10.1126/science.275.5305.1481

M. Hajjar, D. Lacoste, and G. Brossard, Non-Acquired Immune Deficiency Syndrome-Defining Malignancies in a Hospital-Based Cohort of Human Immunodeficiency Virus-Infected Patients: Bordeaux, France, 1985-1991, JNCI Journal of the National Cancer Institute, vol.84, issue.20, pp.1593-1598, 1992.
DOI : 10.1093/jnci/84.20.1593
URL : https://hal.archives-ouvertes.fr/inserm-00263477

R. Thiebaut, P. Morlat, and H. Jacqmin-gadda, Clinical progression of HIV-1 infection according to the viral response during the first year of antiretroviral treatment, AIDS, vol.14, issue.8, pp.971-979, 2000.
DOI : 10.1097/00002030-200005260-00008

C. Lewden, G. Chene, and P. Morlat, HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population, J Acquir Immune Defic Syndr, vol.46, pp.72-79, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00170726

D. Commenges, L. Letenneur, and P. Joly, RE: "SERUM TRANSFERRIN SATURATION, STROKE INCIDENCE, AND MORTALITY IN WOMEN AND MEN. THE NHANES I EPIDEMIOLOGIC FOLLOWUP STUDY", American Journal of Epidemiology, vol.146, issue.8
DOI : 10.1093/oxfordjournals.aje.a009339

N. Breslow and N. Day, Statistical methods in cancer research. Volume II--The design and analysis of cohort studies, IARC Sci Publ, pp.1-406, 1987.

D. Commenges, A. Sarrayeh, L. Letenneur, J. Guedj, and A. Bar-hen, Estimating a difference of Kullback???Leibler risks using a normalized difference of AIC, The Annals of Applied Statistics, vol.2, issue.3, pp.1123-1165, 2008.
DOI : 10.1214/08-AOAS176
URL : https://hal.archives-ouvertes.fr/inserm-00285864

S. Deeks, C. Kitchen, and L. Liu, Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load, Blood, vol.104, issue.4, pp.942-949, 2004.
DOI : 10.1182/blood-2003-09-3333

A. Grulich, M. Van-leeuwen, M. Falster, and C. Vajdic, Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis, The Lancet, vol.370, issue.9581, pp.59-67, 2007.
DOI : 10.1016/S0140-6736(07)61050-2

M. Frisch, R. Biggar, E. Engels, and J. Goedert, Association of Cancer With AIDS-Related Immunosuppression in Adults, JAMA, vol.285, issue.13, pp.1736-1781, 2001.
DOI : 10.1001/jama.285.13.1736

C. Vajdic, S. Mcdonald, and M. Mccredie, Cancer Incidence Before and After Kidney Transplantation, JAMA, vol.296, issue.23, pp.2823-2854, 2006.
DOI : 10.1001/jama.296.23.2823

D. Serraino, P. Piselli, and G. Busnach, Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe, European Journal of Cancer, vol.43, issue.14, pp.2117-2140, 2007.
DOI : 10.1016/j.ejca.2007.07.015

A. Burgi, S. Brodine, and S. Wegner, Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals, Cancer, vol.97, issue.7
DOI : 10.1002/cncr.21334

A. Monforte-'a, Malignancy???Related Deaths among HIV???Infected Patients, Clinical Infectious Diseases, vol.48, issue.5, pp.640-641, 2009.
DOI : 10.1086/596767

L. Remontet, J. Esteve, and A. Bouvier, Cancer incidence and mortality in France over the period, ? . Rev Epidemiol Sante Publique, vol.51, pp.3-30, 2003.
URL : https://hal.archives-ouvertes.fr/hal-00428273